Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults - Robe, Pierre A; Martin, Didier H; Nguyen-Khac, Minh T; Artesi, Maria; Deprez, Manuel; Albert, Adelin; Vanbelle, Sophie; Califice, Stephane; Bredel, Markus; Bours, Vincent (BMC cancer, 2009)
Keywords: Adult; Brain cancer; Brain research; Chemotherapy; Development and progression; Disease Progression; Dosage and administration; Drug dosages; Drug therapy; Early Termination of Clinical Trials; Female; Genetics & genetic processes; Glioma - drug therapy; Glioma - pathology; Glioma/drug therapy/pathology; Gliomas; Génétique & processus génétiques; Humans; Kinases; Life sciences; Male; Medical statistics; Middle Aged; Neurosurgery; Patients; Prospective Studies; Radiation therapy; Sciences du vivant; Software; Sulfasalazine; Sulfasalazine - administration & dosage; Sulfasalazine - adverse effects; Sulfasalazine/administration & dosage/adverse effects; Surgery; Toxicity; Treatment Failure; Tumors; Belgium; United States; United States--US